Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Ebsen, Henriette ^a   Schröder, Alexandra ^a   Kabelitz, Dieter ^a   Janssen, Ottmar ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; CALCIUM IONOPHORE; FAS LIGAND; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL ESTER; PROTEIN ADAM17; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM MOBILIZATION; CANCER CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; T LYMPHOCYTE;

ACTINS; ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GOLGI APPARATUS; HUMANS; MEMBRANE PROTEINS; PROTEIN TRANSPORT; T-LYMPHOCYTES;

EID: 84885150942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076853     Document Type: Article

References (70)

1. Edwards DR, Handsley MM, Pennington CJ, (2008) The ADAM metalloproteinases. Mol Aspects Med 29: 258-289. doi:10.1016/j.mam.2008.08.001. PubMed: 18762209.
2. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385: 733-736. doi:10.1038/385733a0. PubMed: 9034191.
3. Moss ML, Jin SL, Becherer JD, Bickett DM, Burkhart W, et al. (1997) Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). J Neuroimmunol 72: 127-129. doi:10.1016/S0165-5728(96)00180-4. PubMed: 9042103.
4. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733. doi:10.1038/385729a0. PubMed: 9034190.
5. Scheller J, Chalaris A, Garbers C, Rose-John S, (2011) ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 32: 380-387. doi:10.1016/j.it.2011.05.005. PubMed: 21752713.
6. Saftig P, Reiss K, (2011) The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol 90: 527-535. doi:10.1016/j.ejcb.2010.11.005. PubMed: 21194787.
7. Bozkulak EC, Weinmaster G, (2009) Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol Cell Biol 29: 5679-5695. doi:10.1128/MCB.00406-09. PubMed: 19704010.
8. Gibb DR, El SM, Kang DJ, Rowe WJ, El SR, et al. (2010) ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J Exp Med 207: 623-635. doi:10.1084/jem.20091990. PubMed: 20156974.
9. Tian L, Wu X, Chi C, Han M, Xu T, et al. (2008) ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int Immunol 20: 1181-1187. doi:10.1093/intimm/dxn076. PubMed: 18635581.
10. van Tetering G, van Diest P, Verlaan I, van der Wall E, Kopan R, Vooijs Mvan TG, van DP, Verlaan I, van der WE, Kopan R,et al (2009) Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem 284: 31018-31027. doi:10.1074/jbc.M109.006775. PubMed: 19726682.
11. Weber S, Niessen MT, Prox J, Lüllmann-Rauch R, Schmitz A, et al. (2011) The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 138: 495-505. doi:10.1242/dev.055210. PubMed: 21205794.
12. Zhang C, Tian L, Chi C, Wu X, Yang X, et al. (2010) Adam10 is essential for early embryonic cardiovascular development. Dev Dyn 239: 2594-2602. doi:10.1002/dvdy.22391. PubMed: 20803506.
13. Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, et al. (2007) ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 14: 1040-1049. PubMed: 17290285.
14. Kirkin V, Cahuzac N, Guardiola-Serrano F, Huault S, Lückerath K, et al. (2007) The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differ 14: 1678-1687. doi:10.1038/sj.cdd.4402175. PubMed: 17557115.
15. Voss M, Lettau M, Paulsen M, Janssen O, (2008) Posttranslational regulation of Fas ligand function. Cell Commun Signal 6: 11. doi:10.1186/1478-811X-6-11. PubMed: 19114018.
16. Paulsen M, Janssen O, (2011) Pro- and anti-apoptotic CD95 signaling in T cells. Cell Commun Signal 9: 7. doi:10.1186/1478-811X-9-7. PubMed: 21477291.
17. Lettau M, Paulsen M, Schmidt H, Janssen O, (2011) Insights into the molecular regulation of FasL (CD178) biology. Eur J Cell Biol 90: 456-466. doi:10.1016/j.ejcb.2010.10.006. PubMed: 21126798.
18. Martin L, Fluhrer R, Reiss K, Kremmer E, Saftig P, et al. (2008) Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J Biol Chem 283: 1644-1652. PubMed: 17965014.
19. Tousseyn T, Thathiah A, Jorissen E, Raemaekers T, Konietzko U, et al. (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J Biol Chem 284: 11738-11747. PubMed: 19213735.
20. Annaert WG, Saftig P, (2009) Regulated intramembrane proteolysis--a story about sheddases and I-CliPs. Semin Cell Dev Biol 20: 125. doi:10.1016/j.semcdb.2009.03.005. PubMed: 19429493.
21. de Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522. doi:10.1038/19083. PubMed: 10206645.
22. Six E, Ndiaye D, Laabi Y, Brou C, Gupta-Rossi N, et al. (2003) The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc Natl Acad Sci U S A 100: 7638-7643. doi:10.1073/pnas.1230693100. PubMed: 12794186.
23. Friedmann E, Hauben E, Maylandt K, Schleeger S, Vreugde S, et al. (2006) SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production. Nat Cell Biol 8: 843-848. doi:10.1038/ncb1440. PubMed: 16829952.
24. Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan-Vague I, et al. (2006) The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res 312: 3969-3980. doi:10.1016/j.yexcr.2006.08.027. PubMed: 17010968.
25. Parr-Sturgess CA, Rushton DJ, Parkin ET, (2010) Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event. Biochem J 432: 283-294. doi:10.1042/BJ20100321. PubMed: 20819075.
26. Lettau M, Qian J, Linkermann A, Latreille M, Larose L, et al. (2006) The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci U S A 103: 5911-5916. doi:10.1073/pnas.0508562103. PubMed: 16595635.
27. Sipos B, Möser S, Kalthoff H, Török V, Löhr M, et al. (2003) A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 442: 444-452. PubMed: 12692724.
28. Trad A, Hedemann N, Shomali M, Pawlak V, Grötzinger J, et al. (2011) Development of sandwich ELISA for detection and quantification of human and murine a disintegrin and metalloproteinase17. J Immunol Methods 371: 91-96. doi:10.1016/j.jim.2011.06.015. PubMed: 21726562.
29. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, et al. (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164: 769-779. doi:10.1083/jcb.200307137. PubMed: 14993236.
30. Sanderson MP, Erickson SN, Gough PJ, Garton KJ, Wille PT, et al. (2005) ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J Biol Chem 280: 1826-1837. PubMed: 15507448.
31. Lettau M, Qian J, Kabelitz D, Janssen O, (2004) Activation-dependent FasL expression in T lymphocytes and Natural Killer cells. Signal Transduct 4: 206-211. doi:10.1002/sita.200400037.
32. Lettau M, Schmidt H, Kabelitz D, Janssen O, (2007) Secretory lysosomes and their cargo in T and NK cells. Immunol Lett 108: 10-19. doi:10.1016/j.imlet.2006.10.001. PubMed: 17097742.
33. Stoeck A, Keller S, Riedle S, Sanderson MP, Runz S, et al. (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 393: 609-618. doi:10.1042/BJ20051013. PubMed: 16229685.
34. Nagano O, Murakami D, Hartmann D, De SB, Saftig P, et al. (2004) Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165: 893-902. doi:10.1083/jcb.200310024. PubMed: 15197174.
35. Horiuchi K, Le GS, Schulte M, Yamaguchi T, Reiss K, et al. (2007) Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Cell Biol 18: 176-188. PubMed: 17079736.
36. Guo S, Peng M, Zhao Q, Zhang W, (2012) Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators. Chin Med Sci J 27: 73-79. PubMed: 22770404.
37. Moss ML, Powell G, Miller MA, Edwards L, Qi B, et al. (2011) ADAM9 inhibition increases membrane activity of ADAM10 and controls alpha-secretase processing of amyloid precursor protein. J Biol Chem 286: 40443-40451. doi:10.1074/jbc.M111.280495. PubMed: 21956108.
38. Soond SM, Everson B, Riches DW, Murphy G, (2005) ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 118: 2371-2380. doi:10.1242/jcs.02357. PubMed: 15923650.
39. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M, (2012) Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335: 225-228. doi:10.1126/science.1214400. PubMed: 22246777.
40. McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, et al. (2012) iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335: 229-232. doi:10.1126/science.1214448. PubMed: 22246778.
41. Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, et al. (2003) ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17: 292-294. PubMed: 12475894.
42. Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM, (2000) Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J Biol Chem 275: 2568-2575. doi:10.1074/jbc.275.4.2568. PubMed: 10644715.
43. Shirakabe K, Wakatsuki S, Kurisaki T, Fujisawa-Sehara A, (2001) Roles of Meltrin beta/ADAM19 in the processing of neuregulin. J Biol Chem 276: 9352-9358. doi:10.1074/jbc.M007913200. PubMed: 11116142.
44. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Watzl C, et al. (2008) 2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Proteomics 8: 2911-2925. doi:10.1002/pmic.200800170. PubMed: 18655029.
45. Schmidt H, Gelhaus C, Lucius R, Nebendahl M, Leippe M, et al. (2009) Enrichment and analysis of secretory lysosomes from lymphocyte populations. BMC Immunol 10: 41. doi:10.1186/1471-2172-10-41. PubMed: 19640298.
46. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, et al. (2011) Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells. Cell Commun Signal 9: 4. doi:10.1186/1478-811X-9-4. PubMed: 21255389.
47. Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, et al. (2011) Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J Proteome Res 10: 1603-1620. doi:10.1021/pr100967v. PubMed: 21247065.
48. Rose-John S, (2013) ADAM17, shedding, TACE as therapeutic targets. Pharmacol Res 71: 19-22. doi:10.1016/j.phrs.2013.01.012. PubMed: 23415892.
49. Reiss K, Saftig P, (2009) The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 20: 126-137. doi:10.1016/j.semcdb.2008.11.002. PubMed: 19049889.
50. Myers TJ, Brennaman LH, Stevenson M, Higashiyama S, Russell WE, et al. (2009) Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-alpha shedding. Mol Cell Biol 20: 5236-5249. doi:10.1091/mbc.E08-12-1256. PubMed: 19846666.
51. Yin J, Yu FS, (2009) ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 50: 132-139. PubMed: 18658095.
52. Holback S, Adlerz L, Gatsinzi T, Jacobsen KT, Iverfeldt K, (2008) PI3-K- and PKC-dependent up-regulation of APP processing enzymes by retinoic acid. Biochem Biophys Res Commun 365: 298-303. doi:10.1016/j.bbrc.2007.10.167. PubMed: 17986385.
53. Kveiborg M, Instrell R, Rowlands C, Howell M, Parker PJ, (2011) PKCalpha and PKCdelta regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways. PLOS ONE 6: e17168. doi:10.1371/journal.pone.0017168. PubMed: 21386996.
54. Lemjabbar-Alaoui H, Sidhu SS, Mengistab A, Gallup M, Basbaum C, (2011) TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells. PLOS ONE 6: e17489. doi:10.1371/journal.pone.0017489. PubMed: 21423656.
55. Walev I, Vollmer P, Palmer M, Bhakdi S, Rose-John S, (1996) Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci U S A 93: 7882-7887. doi:10.1073/pnas.93.15.7882. PubMed: 8755571.
56. Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, et al. (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110: 1748-1755. doi:10.1182/blood-2007-01-067918. PubMed: 17567983.
57. Maretzky T, Schulte M, Ludwig A, Rose-John S, Blobel C, et al. (2005) L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol 25: 9040-9053. doi:10.1128/MCB.25.20.9040-9053.2005. PubMed: 16199880.
58. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, et al. (2005) Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8: 161-171. doi:10.2174/1386207053258488. PubMed: 15777180.
59. Hougaard S, Loechel F, Xu X, Tajima R, Albrechtsen R, et al. (2000) Trafficking of human ADAM 12-L: retention in the trans-Golgi network. Biochem Biophys Res Commun 275: 261-267. doi:10.1006/bbrc.2000.3295. PubMed: 10964655.
60. Sundberg C, Thodeti CK, Kveiborg M, Larsson C, Parker P, et al. (2004) Regulation of ADAM12 cell-surface expression by protein kinase C epsilon. J Biol Chem 279: 51601-51611. doi:10.1074/jbc.M403753200. PubMed: 15364951.
61. Dornier E, Coumailleau F, Ottavi JF, Moretti J, Boucheix C, et al. (2012) TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals. J Cell Biol 199: 481-496. doi:10.1083/jcb.201201133. PubMed: 23091066.
62. Haining EJ, Yang J, Bailey RL, Khan K, Collier R, et al. (2012) The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression. J Biol Chem 287: 39753-39765. doi:10.1074/jbc.M112.416503. PubMed: 23035126.
63. Xu D, Sharma C, Hemler ME, (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 23: 3674-3681. doi:10.1096/fj.09-133462. PubMed: 19587294.
64. Gutiérrez-López MD, Gilsanz A, Yáñez-Mó M, Ovalle S, Lafuente EM, et al. (2011) The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cell Mol Life Sci 68: 3275-3292. doi:10.1007/s00018-011-0639-0. PubMed: 21365281.
65. Bell HL, Gööz M, (2010) ADAM-17 is activated by the mitogenic protein kinase ERK in a model of kidney fibrosis. Am J Med Sci 339: 105-107. doi:10.1097/MAJ.0b013e3181cb4487. PubMed: 20087163.
66. Göoz M, Göoz P, Luttrell LM, Raymond JR, (2006) 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J Biol Chem 281: 21004-21012. doi:10.1074/jbc.M512096200. PubMed: 16737974.
67. Xiao LJ, Lin P, Lin F, Liu X, Qin W, et al. (2012) ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol 40: 1714-1724. PubMed: 22200661.
68. Doedens JR, Black RA, (2000) Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275: 14598-14607. doi:10.1074/jbc.275.19.14598. PubMed: 10799546.
69. Blott EJ, Griffiths GM, (2002) Secretory lysosomes. Nat Rev Mol Cell Biol 3: 122-131. doi:10.1038/nrm732. PubMed: 11836514.
70. Bossi G, Griffiths GM, (2005) CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin Immunol 17: 87-94. doi:10.1016/j.smim.2004.09.007. PubMed: 15582491.